Abstract
In 1809, a Scottish surgeon named James Wardrop wrote a monograph where he described a subset of fungus haematodes distinguishing them from other cases of “soft cancer,” “medullary sarcoma,” or inflammation. He was the first to recognize retinoblastoma (RB) as a discrete tumor arising primarily from the retina [1]. Virchow in 1864 used the name glioma retinae because of retinoblastoma’s similarity to intracranial glial tumors. Verhoeff, in 1922, observed the retinal origin and the presence of immature, embryonic cells that formed the tumor and coined the term retinoblastoma. In 1926, the American Ophthalmological Society accepted the term retinoblastoma and the older terms, such as glioma retinae and fungus haematodes, were abandoned [2]. In 1809, it was the astute clinical observations and descriptions of the disease that made the diagnosis of what we now know as retinoblastoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kivelä T. 200 years of success initiated by James Wardrop’s 1809 monograph on retinoblastoma. Acta Ophthalmol. 2009;87:810–2.
Dunphy EB. The story of retinoblastoma. Am J Ophthalmol. 1964;58:539–52.
Maki JL, Marr BP, Abramson DH. Diagnosis of retinoblastoma: how good are referring physicians? Ophthalmic Genet. 2009;30:199–205.
Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73:692–8.
Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer. 1982;45:513–21.
Lin BA, Messieha ZS, Hoffman WE. Safety and efficacy of pediatric general anesthesia by laryngeal mask airway without intravenous access. Int J Clin Med. 2011;2:328–31.
Sterns GK, Coleman DJ, Ellsworth RM. Characterization and evaluation of retinoblastoma by ultrasonography. Bibl Ophthalmol. 1975;83:125–9.
Abramson DH, Ellsworth RM. Ancillary tests for the diagnosis of retinoblastoma. Bull N Y Acad Med. 1980;56:221–31.
Liu CY, Jonna G, Francis JH, Marr BP, Abramson DH, Brodie SE. Non-selectivity of ERG reductions in eyes treated for retinoblastoma. Doc Ophthalmol. 2014;128:13–23.
Francis JH, Abramson DH, Marr BP, Brodie SE. Ocular manipulation reduces both ipsilateral and contralateral electroretinograms. Doc Ophthalmol. 2013;127:113–22.
Albert DM. Trilateral retinoblastoma: insights into histogenesis and management. Surv Ophthalmol. 1998;43:59–70.
de Graaf P, Göricke S, Rodjan F, Galluzzi P, Maeder P, Castelijns JA, Brisse HJ, European Retinoblastoma Imaging Collaboration (ERIC). Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14.
Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd 3rd NW. Presenting signs of retinoblastoma. J Pediatr. 1998;132(3 Pt 1):505–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marr, B.P., Singh, A.D. (2015). Retinoblastoma: Evaluation and Diagnosis. In: Singh, A., Murphree, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43451-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-43451-2_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43450-5
Online ISBN: 978-3-662-43451-2
eBook Packages: MedicineMedicine (R0)